Publication | Open Access
First-line nivolumab plus ipilimumab versus chemotherapy for the treatment of unresectable malignant pleural mesothelioma: patient-reported outcomes in CheckMate 743
34
Citations
22
References
2022
Year
| Year | Citations | |
|---|---|---|
Page 1
Page 1